US growth may be a bit bumpy due to healthcare reforms
UK growth won't see immediate revenue but will see ongoing and higher revenue due to model
R&D and expenses due to international growth
Overall, solid report and Nanosonics focused on long term dominant position instead of short term bottom line - how it should be!
US growth may be a bit bumpy due to healthcare reforms UK growth...
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.65 |
Change
0.080(2.24%) |
Mkt cap ! $1.105B | |||
| Open | High | Low | Value | Volume |
| $3.61 | $3.65 | $3.56 | $3.430M | 949.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1374 | $3.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.65 | 4932 | 2 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| NAN (ASX) Chart |